-
1
-
-
30444437486
-
Treatment of acute lymphoblastic leukemia
-
DOI 10.1056/NEJMra052603
-
Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166-78. (Pubitemid 43076714)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.2
, pp. 166-178
-
-
Pui, C.-H.1
Evans, W.E.2
-
2
-
-
0034525989
-
Children's cancer group trials in childhood acute lymphoblastic leukemia: 1983-1995
-
DOI 10.1038/sj.leu.2401939
-
Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia. 2000;14 (12):2223-33. (Pubitemid 32042263)
-
(2000)
Leukemia
, vol.14
, Issue.12
, pp. 2223-2233
-
-
Gaynon, P.S.1
Trigg, M.E.2
Heerema, N.A.3
Sensel, M.G.4
Sather, H.N.5
Hammond, G.D.6
Bleyer, W.A.7
-
3
-
-
84861227040
-
Increased survival of children with solid tumours: How did we get there and how to keep the success going?
-
Rechnitzer C. Increased survival of children with solid tumours: how did we get there and how to keep the success going? Canc Imag. 2011;11:865-9.
-
(2011)
Canc Imag
, vol.11
, pp. 865-869
-
-
Rechnitzer, C.1
-
4
-
-
79958043675
-
-
National Cancer Institute, Bethesda, MD;
-
Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD; 2010.
-
SEER Cancer Statistics Review, 1975-2008
, pp. 2010
-
-
Howlader, N.1
Noone, A.M.2
Krapcho, M.3
Neyman, N.4
Aminou, R.5
Waldron, W.6
-
5
-
-
0033944214
-
The role of the preBCR, the interleukin-7 receptor, and homotypic interactions during B-cell development
-
DOI 10.1034/j.1600-065X.2000.017511.x
-
Stoddart A, Fleming HE, Paige CJ. The role of the preBCR, the interleukin-7 receptor, and homotypic interactions during B-cell development. Immunol Rev. 2000;175:47-58. (Pubitemid 30427155)
-
(2000)
Immunological Reviews
, vol.175
, pp. 47-58
-
-
Stoddart, A.1
Fleming, H.E.2
Paige, C.J.3
-
6
-
-
20844435467
-
The NF1 tumor suppressor critically regulates TSC2 and mTOR
-
DOI 10.1073/pnas.0503224102
-
Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A. 2005;102 (24):8573-8. (Pubitemid 40862777)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.24
, pp. 8573-8578
-
-
Johannessen, C.M.1
Reczek, E.E.2
James, M.F.3
Brems, H.4
Legius, E.5
Cichowski, K.6
-
7
-
-
16844375160
-
Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors
-
DOI 10.1158/0008-5472.CAN-04-4058
-
Dasgupta B, Yi Y, Chen DY, Weber JD, Gutmann DH. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res. 2005;65(7):2755-60. (Pubitemid 40490077)
-
(2005)
Cancer Research
, vol.65
, Issue.7
, pp. 2755-2760
-
-
Dasgupta, B.1
Yi, Y.2
Chen, D.Y.3
Weber, J.D.4
Gutmann, D.H.5
-
8
-
-
34247373748
-
AKT1 overexpression in endothelial cells leads to the development of cutaneous vascular malformations in vivo
-
DOI 10.1001/archderm.143.4.504
-
Perry B, Banyard J, McLaughlin ER,Watnick R, Sohn A, Brindley DN, et al. AKT1 overexpression in endothelial cells leads to the development of cutaneous vascular malformations in vivo. Arch Dermatol. 2007;143(4):504-6. (Pubitemid 46631649)
-
(2007)
Archives of Dermatology
, vol.143
, Issue.4
, pp. 504-506
-
-
Perry, B.1
Banyard, J.2
McLaughlin, E.R.3
Watnick, R.4
Sohn, A.5
Brindley, D.N.6
Obata, T.7
Cantley, L.C.8
Cohen, C.9
Arbiser, J.L.10
-
9
-
-
0036632368
-
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
-
Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2(7):489-501. (Pubitemid 37328931)
-
(2002)
Nature Reviews Cancer
, vol.2
, Issue.7
, pp. 489-501
-
-
Vivanco, I.1
Sawyers, C.L.2
-
10
-
-
65949088837
-
Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia
-
Chiarini F, Fala F, Tazzari PL, Ricci F, Astolfi A, Pession A, et al. Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia. Cancer Res. 2009;69 (8):3520-8.
-
(2009)
Cancer Res
, vol.69
, Issue.8
, pp. 3520-3528
-
-
Chiarini, F.1
Fala, F.2
Tazzari, P.L.3
Ricci, F.4
Astolfi, A.5
Pession, A.6
-
12
-
-
2342559981
-
The TOR pathway: A target for cancer therapy
-
Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer. 2004;4(5):335-48. (Pubitemid 38579480)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.5
, pp. 335-348
-
-
Bjornsti, M.-A.1
Houghton, P.J.2
-
13
-
-
34047095297
-
The two TORCs and Akt
-
DOI 10.1016/j.devcel.2007.03.020, PII S1534580707001207
-
Bhaskar PT, Hay N. The two TORCs and Akt. Developmental Cell. 2007;12(4):487-502. (Pubitemid 46523652)
-
(2007)
Developmental Cell
, vol.12
, Issue.4
, pp. 487-502
-
-
Bhaskar, P.T.1
Hay, N.2
-
14
-
-
13844312400
-
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
-
DOI 10.1126/science.1106148
-
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307(5712):1098- 101. (Pubitemid 40262113)
-
(2005)
Science
, vol.307
, Issue.5712
, pp. 1098-1101
-
-
Sarbassov, D.D.1
Guertin, D.A.2
Ali, S.M.3
Sabatini, D.M.4
-
15
-
-
0033674591
-
Malignancy in neurofibromatosis type 1
-
Korf BR. Malignancy in neurofibromatosis type 1. Oncologist. 2000;5(6):477-85.
-
(2000)
Oncologist
, vol.5
, Issue.6
, pp. 477-485
-
-
Korf, B.R.1
-
16
-
-
0034081412
-
Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects
-
DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N
-
Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van RN, et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000;15 (6):541-55. (Pubitemid 30368440)
-
(2000)
Human Mutation
, vol.15
, Issue.6
, pp. 541-555
-
-
Messiaen, L.M.1
Callens, T.2
Mortier, G.3
Beysen, D.4
Vandenbroucke, I.5
Van Roy, N.6
Speleman, F.7
De Paepe, A.8
-
17
-
-
0023652654
-
-
US Department of Health and Human Services, National Institutes of Health. NIH Consens Statement Online Jul 13-15
-
US Department of Health and Human Services, National Institutes of Health. Neurofibromatosis. NIH Consens Statement Online 1987 Jul 13-15;6(12):1-19.
-
(1987)
Neurofibromatosis
, vol.6
, Issue.12
, pp. 1-19
-
-
-
19
-
-
33644667931
-
Pediatric malignant peripheral nerve sheath tumor: The Italian and German soft tissue sarcoma cooperative group
-
Carli M, Ferrari A, Mattke A, et al. Pediatric malignant peripheral nerve sheath tumor: The Italian and German soft tissue sarcoma cooperative group. J Clin Oncol. 2005;23:8422-30.
-
(2005)
J Clin Oncol
, vol.23
, pp. 8422-8430
-
-
Carli, M.1
Ferrari, A.2
Mattke, A.3
-
20
-
-
0036096489
-
Malignant peripheral nerve sheath tumours in neurofibromatosis
-
Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis. J Mol Genet. 2002;39:311-4. (Pubitemid 34526349)
-
(2002)
Journal of Medical Genetics
, vol.39
, Issue.5
, pp. 311-314
-
-
Evans, D.G.R.1
Baser, M.E.2
McGaughran, J.3
Sharif, S.4
Howard, E.5
Moran, A.6
-
21
-
-
0030732579
-
Prognostic signs in the surgical management of plexiform neurofibroma: The children's hospital of Philadelphia experience, 1974-1994
-
Needle MN, Cnaan A, Dattilo J, Chatten J, Phillips PC, Shochat S, et al. Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994. J Pediatr. 1997;131(5):678-82. (Pubitemid 27524844)
-
(1997)
Journal of Pediatrics
, vol.131
, Issue.5
, pp. 678-682
-
-
Needle, M.N.1
Cnaan, A.2
Dattilo, J.3
Chatten, J.4
Phillips, P.C.5
Shochat, S.6
Sutton, L.N.7
Vaughan, S.N.8
Zackai, E.H.9
Zhao, H.10
Molloy, P.T.11
-
22
-
-
0024205878
-
Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales
-
Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain. 1988;111(Pt 6):1355-81. (Pubitemid 19028458)
-
(1988)
Brain
, vol.111
, Issue.6
, pp. 1355-1381
-
-
Huson, S.M.1
Harper, P.S.2
Compston, D.A.S.3
-
24
-
-
0035025409
-
Mortality in neurofibromatosis 1: An analysis using U.S. death certificates
-
DOI 10.1086/320121
-
Rasmussen SA, Yang Q, Friedman JM. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. 2001;68(5):1110-8. (Pubitemid 32424410)
-
(2001)
American Journal of Human Genetics
, vol.68
, Issue.5
, pp. 1110-1118
-
-
Rasmussen, S.A.1
Yang, Q.2
Friedman, J.M.3
-
25
-
-
3042793769
-
Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging
-
DOI 10.1016/j.compmedimag.2004.03.002, PII S0895611104000370
-
Solomon J, Warren K, Dombi E, et al. Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging. Comput Med Imag Graph. 2004;28:257-65. (Pubitemid 38891818)
-
(2004)
Computerized Medical Imaging and Graphics
, vol.28
, Issue.5
, pp. 257-265
-
-
Solomon, J.1
Warren, K.2
Dombi, E.3
Patronas, N.4
Widemann, B.5
-
26
-
-
0037435522
-
Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1
-
Gupta A, Cohen BH, Ruggieri P, Packer RJ, Phillips PC. Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1. Neurology. 2003;60(1):130-2. (Pubitemid 36070662)
-
(2003)
Neurology
, vol.60
, Issue.1
, pp. 130-132
-
-
Gupta, A.1
Cohen, B.H.2
Ruggieri, P.3
Packer, R.J.4
Phillips, P.C.5
-
27
-
-
33644838556
-
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas
-
DOI 10.1200/JCO.2005.03.8638
-
Widemann BC, Salzer WL, Arceci RJ, Blaney SM, Fox E, End D, et al. Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. J Clin Oncol. 2006;24(3):507-16. (Pubitemid 46630471)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.3
, pp. 507-516
-
-
Widemann, B.C.1
Salzer, W.L.2
Arceci, R.J.3
Blaney, S.M.4
Fox, E.5
End, D.6
Gillespie, A.7
Whitcomb, P.8
Palumbo, J.S.9
Pitney, A.10
Jayaprakash, N.11
Zannikos, P.12
Balis, F.M.13
-
28
-
-
34248177910
-
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas
-
DOI 10.1016/j.pediatrneurol.2007.01.009, PII S0887899407000446
-
Babovic-Vuksanovic D, Widemann BC, Dombi E, Gillespie A, Wolters PL, Toledo-Tamula MA, et al. Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas. Pediatr Neurol. 2007;36(5):293-300. (Pubitemid 46726967)
-
(2007)
Pediatric Neurology
, vol.36
, Issue.5
, pp. 293-300
-
-
Babovic-Vuksanovic, D.1
Widemann, B.C.2
Dombi, E.3
Gillespie, A.4
Wolters, P.L.5
Toledo-Tamula, M.A.6
O'Neill, B.P.7
Fox, E.8
MacDonald, T.9
Beck, H.10
Packer, R.J.11
-
31
-
-
78650987740
-
Tuberous sclerosis complex: Neurological, renal and pulmonary manifestations
-
Franz DN, Bissler JJ, McCormack FX. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics. 2010;41(5):199-208.
-
(2010)
Neuropediatrics
, vol.41
, Issue.5
, pp. 199-208
-
-
Franz, D.N.1
Bissler, J.J.2
McCormack, F.X.3
-
32
-
-
48549098902
-
The pathogenesis and imaging of the tuberous sclerosis complex
-
Baskin Jr HJ. The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol. 2008;38(9):936-52.
-
(2008)
Pediatr Radiol
, vol.38
, Issue.9
, pp. 936-952
-
-
Baskin Jr., H.J.1
-
33
-
-
20544431744
-
Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: Genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex
-
DOI 10.1038/sj.ejhg.5201402
-
Sancak O, Nellist M, Goedbloed M, Elfferich P, Wouters C, Maat- Kievit A, et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype: phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur J Hum Genet. 2005;13(6):731-41. (Pubitemid 40846845)
-
(2005)
European Journal of Human Genetics
, vol.13
, Issue.6
, pp. 731-741
-
-
Sancak, O.1
Nellist, M.2
Goedbloed, M.3
Elfferich, P.4
Wouters, C.5
Maat-Kievit, A.6
Zonnenberg, B.7
Verhoef, S.8
Halley, D.9
Van Den Ouweland, A.10
-
34
-
-
34548018958
-
Hereditary neuroendocrine tumors of the gastroenteropancreatic system
-
DOI 10.1007/s00428-007-0450-3
-
Anlauf M, Garbrecht N, Bauersfeld J, Schmitt A, Henopp T, Komminoth P, et al. Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Arch. 2007;451 Suppl 1:S29-38. (Pubitemid 47283381)
-
(2007)
Virchows Archiv
, vol.451
, Issue.SUPPL. 1
-
-
Anlauf, M.1
Garbrecht, N.2
Bauersfeld, J.3
Schmitt, A.4
Henopp, T.5
Komminoth, P.6
Heitz, P.U.7
Perren, A.8
Kloppel, G.9
-
35
-
-
34247164656
-
Tuberous sclerosis complex and epilepsy: Recent developments and future challenges
-
DOI 10.1111/j.1528-1167.2007.01035.x
-
Holmes GL, Stafstrom CE. Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia. 2007;48(4):617-30. (Pubitemid 46587608)
-
(2007)
Epilepsia
, vol.48
, Issue.4
, pp. 617-630
-
-
Holmes, G.L.1
Stafstrom, C.E.2
Baraban, S.C.3
Bertram, E.4
Bolton, P.5
Brooks-Kayal, A.6
Chugani, H.T.7
Coulter, D.8
Crino, P.9
Delanerolle, N.C.10
Devinsky, O.11
Jacobs, M.12
Jensen, F.E.13
Kapur, J.14
Khazipov, R.15
Kirchstein, T.16
Lonsdale, J.17
Mathern, G.18
Riviello, J.19
Sahin, M.20
Sands, T.21
Sankar, R.22
Schauwecker, P.23
Staley, K.24
Talos, D.25
Thiele, E.26
Taylor, N.27
Dunigan, C.28
Whittemore, V.H.29
more..
-
36
-
-
0032438210
-
Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria
-
Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13(12):624-8. (Pubitemid 29035481)
-
(1998)
Journal of Child Neurology
, vol.13
, Issue.12
, pp. 624-628
-
-
Roach, E.S.1
Gomez, M.R.2
Northrup, H.3
-
37
-
-
79956301399
-
Epithelioid angiomyolipoma: A morphologically distinct variant that mimics a variety of intraabdominal neoplasms
-
Mete O, van der Kwast TH. Epithelioid angiomyolipoma: a morphologically distinct variant that mimics a variety of intraabdominal neoplasms. Arch Pathol Lab Med. 2011;135(5):665-70.
-
(2011)
Arch Pathol Lab Med
, vol.135
, Issue.5
, pp. 665-670
-
-
Mete, O.1
Van Der Kwast, T.H.2
-
38
-
-
39149096244
-
PEComas: The past, the present and the future
-
Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Archive. 2008;452(2):119-32.
-
(2008)
Virchows Archive
, vol.452
, Issue.2
, pp. 119-132
-
-
Martignoni, G.1
Pea, M.2
Reghellin, D.3
Zamboni, G.4
Bonetti, F.5
-
39
-
-
27744588780
-
Tuberous sclerosis: A GAP at the crossroads of multiple signaling pathways
-
DOI 10.1093/hmg/ddi260
-
Kwiatkowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet. 2005;14(2):R251-8. (Pubitemid 41631882)
-
(2005)
Human Molecular Genetics
, vol.14
, Issue.SUPPL. 2
-
-
Kwiatkowski, D.J.1
Manning, B.D.2
-
40
-
-
37549016789
-
Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation
-
Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia. 2008;49(1):8-21.
-
(2008)
Epilepsia
, vol.49
, Issue.1
, pp. 8-21
-
-
Wong, M.1
-
41
-
-
58149250332
-
Are cortical tubers epileptogenic? Evidence from electrocorticography
-
Major P, Rakowski S, Simon MV, Cheng ML, Eskandar E, Baron J, et al. Are cortical tubers epileptogenic? Evidence from electrocorticography. Epilepsia. 2009;50(1):147-54.
-
(2009)
Epilepsia
, vol.50
, Issue.1
, pp. 147-154
-
-
Major, P.1
Rakowski, S.2
Simon, M.V.3
Cheng, M.L.4
Eskandar, E.5
Baron, J.6
-
42
-
-
8844234942
-
Epilepsy surgery for children with tuberous sclerosis complex
-
Weiner HL, Ferraris N, LaJoie J, Miles D, Devinsky O. Epilepsy surgery for children with tuberous sclerosis complex. J Child Neurol. 2004;19(9):687-9. (Pubitemid 39530078)
-
(2004)
Journal of Child Neurology
, vol.19
, Issue.9
, pp. 687-689
-
-
Weiner, H.L.1
Ferraris, N.2
LaJoie, J.3
Miles, D.4
Devinsky, O.5
-
43
-
-
50849087685
-
Behavior problems in children with tuberous sclerosis complex and parental stress
-
Kopp CM, Muzykewicz DA, Staley BA, Thiele EA, Pulsifer MB. Behavior problems in children with tuberous sclerosis complex and parental stress. Epilepsy Behavior. 2008;13(3):505-10.
-
(2008)
Epilepsy Behavior
, vol.13
, Issue.3
, pp. 505-510
-
-
Kopp, C.M.1
Muzykewicz, D.A.2
Staley, B.A.3
Thiele, E.A.4
Pulsifer, M.B.5
-
44
-
-
7044245656
-
Subependymal giant cell tumors in tuberous sclerosis complex
-
Goh S, Butler W, Thiele EA. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology. 2004;63(8):1457-61. (Pubitemid 39426281)
-
(2004)
Neurology
, vol.63
, Issue.8
, pp. 1457-1461
-
-
Goh, S.1
Butler, W.2
Thiele, E.A.3
-
45
-
-
65449177228
-
Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature
-
Adriaensen ME, Schaefer-Prokop CM, Stijnen T, Duyndam DA, Zonnenberg BA, Prokop M. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol. 2009;16(6):691-6.
-
(2009)
Eur J Neurol
, vol.16
, Issue.6
, pp. 691-696
-
-
Adriaensen, M.E.1
Schaefer-Prokop, C.M.2
Stijnen, T.3
Duyndam, D.A.4
Zonnenberg, B.A.5
Prokop, M.6
-
46
-
-
8844240684
-
Behavioral and cognitive aspects of tuberous sclerosis complex
-
Prather P, de Vries PJ. Behavioral and cognitive aspects of tuberous sclerosis complex. J Child Neurol. 2004;19(9):666-74. (Pubitemid 39530075)
-
(2004)
Journal of Child Neurology
, vol.19
, Issue.9
, pp. 666-674
-
-
Prather, P.1
De Vries, P.J.2
-
47
-
-
8844285191
-
Managing epilepsy in tuberous sclerosis complex
-
Thiele EA. Managing epilepsy in tuberous sclerosis complex. J Child Neurol. 2004;19(9):680-6. (Pubitemid 39530077)
-
(2004)
Journal of Child Neurology
, vol.19
, Issue.9
, pp. 680-686
-
-
Thiele, E.A.1
-
48
-
-
70449714191
-
Current trends in the treatment of infantile spasms
-
Tsao CY. Current trends in the treatment of infantile spasms. Neuropsychiatric Diseases and Treatment. 2009;5:289-99.
-
(2009)
Neuropsychiatric Diseases and Treatment
, vol.5
, pp. 289-299
-
-
Tsao, C.Y.1
-
49
-
-
70350412265
-
From mTOR to cognition: Molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis
-
Ehninger D, de Vries PJ, Silva AJ. From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J Intellect Disabil Res. 2009;53(10):838-51.
-
(2009)
J Intellect Disabil Res
, vol.53
, Issue.10
, pp. 838-851
-
-
Ehninger, D.1
De Vries, P.J.2
Silva, A.J.3
-
50
-
-
74949121901
-
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex
-
D'Agati E, Moavero R, Cerminara C, Curatolo P. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex. J Child Neurol. 2009;24(10):1282-7.
-
(2009)
J Child Neurol
, vol.24
, Issue.10
, pp. 1282-1287
-
-
D'Agati, E.1
Moavero, R.2
Cerminara, C.3
Curatolo, P.4
-
51
-
-
33846083243
-
Cognitive prognosis of patients with tuberous sclerosis complex
-
DOI 10.1212/01.wnl.0000250330.44291.54, PII 0000611420070102000018
-
Winterkorn EB, Pulsifer MB, Thiele EA. Cognitive prognosis of patients with tuberous sclerosis complex.Neurology. 2007;68(1):62-4. (Pubitemid 46058555)
-
(2007)
Neurology
, vol.68
, Issue.1
, pp. 62-64
-
-
Winterkorn, E.B.1
Pulsifer, M.B.2
Thiele, E.A.3
-
52
-
-
33748780944
-
Lymphangioleiomyomatosis
-
DOI 10.1183/09031936.06.00113303
-
Johnson SR. Lymphangioleiomyomatosis. Eur Respir J. 2006;27 (5):1056-65. (Pubitemid 44911122)
-
(2006)
European Respiratory Journal
, vol.27
, Issue.5
, pp. 1056-1065
-
-
Johnson, S.R.1
-
53
-
-
33749068243
-
Tuberous sclerosis
-
DOI 10.1038/sj.ejhg.5201625, PII 5201625
-
Yates JR. Tuberous sclerosis. Eur J Hum Genet. 2006;14 (10):1065-73. (Pubitemid 44463964)
-
(2006)
European Journal of Human Genetics
, vol.14
, Issue.10
, pp. 1065-1073
-
-
Yates, J.R.W.1
-
54
-
-
8844236164
-
Non-neurologic manifestations of tuberous sclerosis complex
-
Franz DN. Non-neurologic manifestations of tuberous sclerosis complex. J Child Neurol. 2004;19(9):690-8. (Pubitemid 39530079)
-
(2004)
Journal of Child Neurology
, vol.19
, Issue.9
, pp. 690-698
-
-
Franz, D.N.1
-
55
-
-
72149109544
-
Angiomyolipomata: Challenges, solutions, and future prospects based on over 100 cases treated
-
Sooriakumaran P, Gibbs P, Coughlin G, Attard V, Elmslie F, Kingswood C, et al. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int. 2010;105(1):101-6.
-
(2010)
BJU Int
, vol.105
, Issue.1
, pp. 101-106
-
-
Sooriakumaran, P.1
Gibbs, P.2
Coughlin, G.3
Attard, V.4
Elmslie, F.5
Kingswood, C.6
-
56
-
-
39449100827
-
Lymphangioleiomyomatosis: A clinical update
-
DOI 10.1378/chest.07-0898
-
McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest. 2008;133(2):507-16. (Pubitemid 351272412)
-
(2008)
Chest
, vol.133
, Issue.2
, pp. 507-516
-
-
McCormack, F.X.1
-
57
-
-
33644689608
-
Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment
-
DOI 10.1002/med.20049
-
Jozwiak J, Jozwiak S, Oldak M. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment. Med Res Rev. 2006;26(2):160-80. (Pubitemid 43334640)
-
(2006)
Medicinal Research Reviews
, vol.26
, Issue.2
, pp. 160-180
-
-
Jozwiak, J.1
Jozwiak, S.2
Oldak, M.3
-
58
-
-
70449428027
-
Perinatal (fetal and neonatal) tuberous sclerosis: A review
-
Isaacs H. Perinatal (fetal and neonatal) tuberous sclerosis: a review. Am J Perinatol. 2009;26(10):755-60.
-
(2009)
Am J Perinatol
, vol.26
, Issue.10
, pp. 755-760
-
-
Isaacs, H.1
-
59
-
-
44449093081
-
TORC1 is essential for NF1-associated malignancies
-
Johannessen CM, Johnson BW, Williams SM, Chan AW, Reczek EE, Lynch RC, et al. TORC1 is essential for NF1-associated malignancies. Curr Biol. 2008;18(1):56-62.
-
(2008)
Curr Biol
, vol.18
, Issue.1
, pp. 56-62
-
-
Johannessen, C.M.1
Johnson, B.W.2
Williams, S.M.3
Chan, A.W.4
Reczek, E.E.5
Lynch, R.C.6
-
60
-
-
60849130177
-
Genetics and molecular biology of tuberous sclerosis complex
-
Napolioni V, Curatolo P. Genetics and molecular biology of tuberous sclerosis complex. Curr Genom. 2008;9(7):475-87.
-
(2008)
Curr Genom
, vol.9
, Issue.7
, pp. 475-487
-
-
Napolioni, V.1
Curatolo, P.2
-
61
-
-
75349087887
-
Dissecting the role of mTOR: Lessons from mTOR inhibitors
-
Dowling RJ, Topisirovic I, Fonseca BD, Sonenberg N. Dissecting the role of mTOR: lessons from mTOR inhibitors. Biochim Biophys Acta. 2010;1804(3):433-9.
-
(2010)
Biochim Biophys Acta.
, vol.1804
, Issue.3
, pp. 433-439
-
-
Dowling, R.J.1
Topisirovic, I.2
Fonseca, B.D.3
Sonenberg, N.4
-
62
-
-
51949094890
-
Tuberous sclerosis complex proteins control axon formation
-
Choi YJ, Di Nardo A, Kramvis I, Meikle L, Kwiatkowski DJ, Sahin M, et al. Tuberous sclerosis complex proteins control axon formation. Genes Dev. 2008;22(18):2485-95.
-
(2008)
Genes Dev
, vol.22
, Issue.18
, pp. 2485-2495
-
-
Choi, Y.J.1
Di Nardo, A.2
Kramvis, I.3
Meikle, L.4
Kwiatkowski, D.J.5
Sahin, M.6
-
63
-
-
34547168930
-
The tuberous sclerosis complex proteins - A GRIPP on cognition and neurodevelopment
-
DOI 10.1016/j.molmed.2007.06.003, PII S1471491407001086
-
de Vries PJ, Howe CJ. The tuberous sclerosis complex proteins: a GRIPP on cognition and neurodevelopment. Trends Mol Med. 2007;13(8):319-26. (Pubitemid 47126986)
-
(2007)
Trends in Molecular Medicine
, vol.13
, Issue.8
, pp. 319-326
-
-
De Vries, P.J.1
Howe, C.J.2
-
64
-
-
73449090138
-
Diffusion features of white matter in tuberous sclerosis with tractography
-
Krishnan ML, Commowick O, Jeste SS, Weisenfeld N, Hans A, Gregas MC, et al. Diffusion features of white matter in tuberous sclerosis with tractography. Pediatr Neurol. 2010;42(2):101-6.
-
(2010)
Pediatr Neurol
, vol.42
, Issue.2
, pp. 101-106
-
-
Krishnan, M.L.1
Commowick, O.2
Jeste, S.S.3
Weisenfeld, N.4
Hans, A.5
Gregas, M.C.6
-
65
-
-
34250626014
-
A mouse model of tuberous sclerosis: Neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival
-
DOI 10.1523/JNEUROSCI.5540-06.2007
-
Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, et al.Amousemodel of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci. 2007;27(21):5546-58. (Pubitemid 350021088)
-
(2007)
Journal of Neuroscience
, vol.27
, Issue.21
, pp. 5546-5558
-
-
Meikle, L.1
Talos, D.M.2
Onda, H.3
Pollizzi, K.4
Rotenberg, A.5
Sahin, M.6
Jensen, F.E.7
Kwiatkowski, D.J.8
-
66
-
-
58249127284
-
Recent advances in neurobiology of tuberous sclerosis complex
-
Napolioni V, Moavero R, Curatolo P. Recent advances in neurobiology of tuberous sclerosis complex. Brain Dev. 2009;31(2):104-13.
-
(2009)
Brain Dev
, vol.31
, Issue.2
, pp. 104-113
-
-
Napolioni, V.1
Moavero, R.2
Curatolo, P.3
-
67
-
-
38149062059
-
Role of mTOR in physiology and pathology of the nervous system
-
Swiech L, Perycz M, Malik A, Jaworski J. Role of mTOR in physiology and pathology of the nervous system. Biochim Biophys Acta. 2008;1784(1):116-32.
-
(2008)
Biochim Biophys Acta
, vol.1784
, Issue.1
, pp. 116-132
-
-
Swiech, L.1
Perycz, M.2
Malik, A.3
Jaworski, J.4
-
68
-
-
28044456974
-
Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
-
DOI 10.1038/nn1566, PII N1566
-
Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci. 2005;8(12):1727-34. (Pubitemid 41683201)
-
(2005)
Nature Neuroscience
, vol.8
, Issue.12
, pp. 1727-1734
-
-
Tavazoie, S.F.1
Alvarez, V.A.2
Ridenour, D.A.3
Kwiatkowski, D.J.4
Sabatini, B.L.5
-
69
-
-
8844224854
-
Molecular pathogenesis of tuber formation in tuberous sclerosis complex
-
Crino PB. Molecular pathogenesis of tuber formation in tuberous sclerosis complex. J Child Neurol. 2004;19(9):716-25. (Pubitemid 39530082)
-
(2004)
Journal of Child Neurology
, vol.19
, Issue.9
, pp. 716-725
-
-
Crino, P.B.1
-
70
-
-
78649330303
-
Epilepsy secondary to tuberous sclerosis: Lessons learned and current challenges
-
Moavero R, Cerminara C, Curatolo P. Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. Childs Nerv Syst. 2010;26(11):1495-504.
-
(2010)
Childs Nerv Syst
, vol.26
, Issue.11
, pp. 1495-1504
-
-
Moavero, R.1
Cerminara, C.2
Curatolo, P.3
-
71
-
-
49149088555
-
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis
-
Ehninger D, Han S, Shilyansky C, Zhou Y, LiW, Kwiatkowski DJ, et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med. 2008;14(8):843-8.
-
(2008)
Nat Med
, vol.14
, Issue.8
, pp. 843-848
-
-
Ehninger, D.1
Han, S.2
Shilyansky, C.3
Zhou, Y.4
Liw Kwiatkowski, D.J.5
-
72
-
-
59749096847
-
Therapeutic targeting of mTOR in tuberous sclerosis
-
Sampson JR. Therapeutic targeting of mTOR in tuberous sclerosis. Biochem Soc Trans. 2009;37(Pt 1):259-64.
-
(2009)
Biochem Soc Trans
, vol.37
, Issue.PART 1
, pp. 259-264
-
-
Sampson, J.R.1
-
73
-
-
76249084241
-
Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies
-
Wong M. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia. 2010;51(1):27-36.
-
(2010)
Epilepsia
, vol.51
, Issue.1
, pp. 27-36
-
-
Wong, M.1
-
74
-
-
42949140259
-
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
-
DOI 10.1002/ana.21331
-
Zeng LH, Xu L, Gutmann DH, Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol. 2008;63(4):444-53. (Pubitemid 351614710)
-
(2008)
Annals of Neurology
, vol.63
, Issue.4
, pp. 444-453
-
-
Zeng, L.-H.1
Xu, L.2
Gutmann, D.H.3
Wong, M.4
-
75
-
-
68149096799
-
The pharmacology of mTOR inhibition
-
Guertin DA, Sabatini DM. The pharmacology of mTOR inhibition. Sci Signal. 2009;2(67):e24.
-
(2009)
Sci Signal
, vol.2
, Issue.67
-
-
Guertin, D.A.1
Sabatini, D.M.2
-
76
-
-
61849157793
-
Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease
-
Brown VI, Seif AE, Reid GS, Teachey DT, Grupp SA. Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease. Immunol Res. 2008;42 (1-3):84-105.
-
(2008)
Immunol Res
, vol.42
, Issue.1-3
, pp. 84-105
-
-
Brown, V.I.1
Seif, A.E.2
Reid, G.S.3
Teachey, D.T.4
Grupp, S.A.5
-
77
-
-
34548205803
-
Rapamycin regulates the phosphorylation of rictor
-
DOI 10.1016/j.bbrc.2007.07.151, PII S0006291X07016464
-
Akcakanat A, Singh G, Hung MC, Meric-Bernstam F. Rapamycin regulates the phosphorylation of rictor. Biochem Biophys Res Commun. 2007;362(2):330-3. (Pubitemid 47332412)
-
(2007)
Biochemical and Biophysical Research Communications
, vol.362
, Issue.2
, pp. 330-333
-
-
Akcakanat, A.1
Singh, G.2
Hung, M.-C.3
Meric-Bernstam, F.4
-
78
-
-
33646023695
-
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
-
Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell. 2006;22(2):159-68.
-
(2006)
Mol Cell
, vol.22
, Issue.2
, pp. 159-168
-
-
Sarbassov, D.D.1
Ali, S.M.2
Sengupta, S.3
Sheen, J.H.4
Hsu, P.P.5
Bagley, A.F.6
-
79
-
-
34147146014
-
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
-
DOI 10.1182/blood-2006-06-030833
-
Zeng Z, Sarbassov DD, Samudio IJ, Yee KW, Munsell MF, Ellen JC, et al. Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Blood. 2007;109(8):3509-12. (Pubitemid 46572543)
-
(2007)
Blood
, vol.109
, Issue.8
, pp. 3509-3512
-
-
Zeng, Z.1
Sarbassov, D.D.2
Samudio, I.J.3
Yee, K.W.L.4
Munsell, M.F.5
Jackson, C.E.6
Giles, F.J.7
Sabatini, D.M.8
Andreeff, M.9
Konopleva, M.10
-
80
-
-
0016713286
-
Rapamycin (AY-22, 989), a new antifungal antibiotic. II. Fermentation, isolation and characterization
-
Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antibiot (Tokyo). 1975;28(10):727-32.
-
(1975)
J Antibiot (Tokyo)
, vol.28
, Issue.10
, pp. 727-732
-
-
Sehgal, S.N.1
Baker, H.2
Vezina, C.3
-
81
-
-
0035165578
-
Rapamycin in transplantation: A review of the evidence
-
DOI 10.1046/j.1523-1755.2001.00460.x
-
Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of the evidence. Kidney Int. 2001;59(1):3-16. (Pubitemid 32055209)
-
(2001)
Kidney International
, vol.59
, Issue.1
, pp. 3-16
-
-
Saunders, R.N.1
Metcalfe, M.S.2
Nicholson, M.L.3
-
82
-
-
33644827461
-
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
-
DOI 10.1002/ana.20784
-
Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol. 2006;59(3):490-8. (Pubitemid 43358069)
-
(2006)
Annals of Neurology
, vol.59
, Issue.3
, pp. 490-498
-
-
Franz, D.N.1
Leonard, J.2
Tudor, C.3
Chuck, G.4
Care, M.5
Sethuraman, G.6
Dinopoulos, A.7
Thomas, G.8
Crone, K.R.9
-
83
-
-
78049510428
-
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis
-
Krueger DA, Care MM, Holland K, Agricola A, Tudor C, Mangeshkar P, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010;363 (19):1801-11.
-
(2010)
N Engl J Med
, vol.363
, Issue.19
, pp. 1801-1811
-
-
Krueger, D.A.1
Care, M.M.2
Holland, K.3
Agricola, A.4
Tudor, C.5
Mangeshkar, P.6
-
85
-
-
38049169559
-
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
-
Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008;358(2):140-51.
-
(2008)
N Engl J Med
, vol.358
, Issue.2
, pp. 140-151
-
-
Bissler, J.J.1
McCormack, F.X.2
Young, L.R.3
Elwing, J.M.4
Chuck, G.5
Leonard, J.M.6
-
86
-
-
41649121721
-
Management of epilepsy in tuberous sclerosis complex
-
DOI 10.1586/14737175.8.3.457
-
Curatolo P, D'Argenzio L, Cerminara C, Bombardieri R. Management of epilepsy in tuberous sclerosis complex. Expert Rev Neurother. 2008;8(3):457-67. (Pubitemid 351480908)
-
(2008)
Expert Review of Neurotherapeutics
, vol.8
, Issue.3
, pp. 457-467
-
-
Curatolo, P.1
D'Argenzio, L.2
Cerminara, C.3
Bombardieri, R.4
-
87
-
-
50649123774
-
Current management of tuberous sclerosis complex
-
Krueger DA, Franz DN. Current management of tuberous sclerosis complex. Paediatric Drugs. 2008;10(5):299-313.
-
(2008)
Paediatric Drugs
, vol.10
, Issue.5
, pp. 299-313
-
-
Krueger, D.A.1
Franz, D.N.2
-
88
-
-
77949420024
-
Tuberous sclerosis complex: A brave new world?
-
Ess KC. Tuberous sclerosis complex: a brave new world? Curr Opin Neurol. 2010;23(2):189-93.
-
(2010)
Curr Opin Neurol
, vol.23
, Issue.2
, pp. 189-193
-
-
Ess, K.C.1
-
89
-
-
58849107874
-
Cardiac rhabdomyoma in tuberous sclerosis: Hyperactive Erk signaling
-
Jozwiak J, Sahin M, Jozwiak S, Kotulska K, Ploski R, Szperl M, et al. Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling. Int J Cardiol. 2009;132(1):145-7.
-
(2009)
Int J Cardiol
, vol.132
, Issue.1
, pp. 145-147
-
-
Jozwiak, J.1
Sahin, M.2
Jozwiak, S.3
Kotulska, K.4
Ploski, R.5
Szperl, M.6
-
90
-
-
63449100787
-
Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities
-
Kotulska K, Larysz-Brysz M, Grajkowska W, Jozwiak J, Wlodarski P, Sahin M, et al. Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities. Pediatr Dev Pathol. 2009;12(2):89-95.
-
(2009)
Pediatr Dev Pathol
, vol.12
, Issue.2
, pp. 89-95
-
-
Kotulska, K.1
Larysz-Brysz, M.2
Grajkowska, W.3
Jozwiak, J.4
Wlodarski, P.5
Sahin, M.6
|